COBALT LABORATORIES
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

COBALT LABORATORIES Trademark

Serial Number: 78714613

COBALT LABORATORIES is a trademark filed by Arrow International Limited on September 16, 2005. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Arrow International Limited (4 trademarks)

57 St. Christopher Street
Valletta , MT

Entity Type: 03

Trademark Details

Filing Date

September 16, 2005

Registration Date

Not Registered

Published for Opposition

January 16, 2007

Goods & Services

Pharmaceutical preparations, namely, preparations for the prevention and treatment of cancers; pharmaceutical preparations, namely, platelet stimulating factors; Pharmaceutical preparations for the treatment of urological disorders, gastrointestinal disorders, allergies, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and fungal disorders; pharmaceutical preparations, namely, anti-inflammatory analgesics; pharmaceutical preparations, namely, smoking cessation preparations, medicated tissue and skin repair preparations; Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations comprising protein kinase or phosphatase for use in the treatment of cancer; pharmaceutical preparations affecting signal transduction pathways for use in the treatment of inflammatory diseases, autoimmune diseases, and psychiatric diseases; Pharmaceutical preparations for the prevention and/or treatment of cancer, carcinomas and sarcomas; Pharmaceutical preparations for the treatment of pains, fever, angina, otorhinolaryngology, gastric and liver illnesses, arterial and venous illnesses, rheumatic illnesses; analgesics, frostbite salve for pharmaceutical purposes, hemorrhoid treatment preparations, pharmaceutical preparations for the treatment of headaches, bath salts for medical purposes, medicated mouthwashes, herbal mud packs for therapeutic purposes, magnetic bracelets for medical purposes, tranquilizers, sedatives, tobacco free cigarettes for medical purposes, medicines for alleviating constipation, contraceptives chemical preparations, radiological contrast substances for medical purposes, namely, contrast media for in-vivo imaging, corn remedies, namely, corn creams, corn pads and corn plasters, cotton for medical purposes, diagnostic preparations for medical purposes, pharmaceutical preparations for the treatment of pain, fever, angina otorhinolaryngology, gastric and liver illnesses, arterial and venous illnesses, rheumatic illnesses, mineral water for medical purposes; Pharmaceutical preparations for the treatment of smooth muscle disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, tremors, namely, spasmodic smooth, striated or cardiac muscles; pharmaceutical preparations for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labor pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical preparations for the treatment of muscle dystonias, nerve disorders, spasmodic striated, smooth or cardiac muscles; pharmaceutical preparations for the treatment of cerebral palsy. Pharmaceutical preparations and substances, namely, anti-infective, anti-bacterials, antivirals, hemostatic agents, pharmaceutical preparations and substances for the treatment of cancer, HIV, obesity and urologic disorders and diseases; pharmaceutical preparations and substances for the treatment of acute ischemic stroke and traumatic brain injury (TBI), cerebral vasodilators; Prescription pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the peripheral nervous system, gastro-intestinal system; prescription pharmaceutical preparations and substances for use in pain control, anesthetics for surgical and non-surgical use; pharmaceutical preparations for use in oncology for the prevention and treatment of disorders

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Apr 12, 2010 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 12, 2010 ABN6
DIVISIONAL PROCESSING COMPLETE
Nov 13, 2009 DPCC
SOU EXTENSION 4 GRANTED
Nov 13, 2009 EX4G
RESPONSE TO ITU OFFICE ACTION ENTERED
Oct 20, 2009 IROA
FAX RECEIVED
Oct 20, 2009 FAXX
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Sep 25, 2009 INCD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 23, 2009 AITU
DIVISIONAL REQUEST RECEIVED
Sep 11, 2009 DRRR
SOU EXTENSION 4 FILED
Sep 11, 2009 EXT4
TEAS REQUEST TO DIVIDE RECEIVED
Sep 11, 2009 ERTD
SOU TEAS EXTENSION RECEIVED
Sep 11, 2009 EEXT
SOU EXTENSION 3 GRANTED
Mar 11, 2009 EX3G
SOU EXTENSION 3 FILED
Mar 11, 2009 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 11, 2009 EEXT
SOU EXTENSION 2 GRANTED
Sep 11, 2008 EX2G
SOU EXTENSION 2 FILED
Sep 11, 2008 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 11, 2008 EEXT
SOU EXTENSION 1 GRANTED
Mar 31, 2008 EX1G
SOU EXTENSION 1 FILED
Mar 11, 2008 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 11, 2008 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 11, 2007 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 31, 2007 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 12, 2007 ETOF
PUBLISHED FOR OPPOSITION
Jan 16, 2007 PUBO
NOTICE OF PUBLICATION
Dec 27, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 30, 2006 PREV
ASSIGNED TO LIE
Nov 30, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 13, 2006 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 2, 2006 TROA
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 1, 2006 GEAP
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Apr 1, 2006 CPEA
ASSIGNED TO EXAMINER
Mar 25, 2006 DOCK
NEW APPLICATION ENTERED
Sep 23, 2005 NWAP